BCHE and early-onset autosomal dominant Alzheimer disease: This work has added to the body of knowledge regarding symmetric azines as putative cholinesterase inhibitors, so broadening the range of possible drugs for the treatment of conditions involving cholinergic dysfunction, including Alzheimer's disease [125].